Lecture
This lecture discusses the stark inequalities in COVID-19 vaccine distribution between rich and poor countries, highlighting the challenges faced by low-income nations. It explores the impact of booster doses in high-income countries and the lack of access to vaccines in developing nations. The presentation delves into the ethical implications of vaccine distribution, patent networks, and the role of pharmaceutical companies. It also addresses the importance of transparency in clinical trials, the need for sharing vaccine technology, and the ethical considerations surrounding drug pricing and research costs. The lecture concludes by advocating for fair pricing, transparency, and legal solutions to address the issues of patent abuse and high drug costs.